Sara Morse is named as a lobbyist on federal disclosure filings for 25 clients through Brownstein Hyatt Farber Schreck, LLP and 1 other registrant. The most recent filing naming them posted in November 2026. Issues reported include Health Issues, Pharmacy, Medicare/Medicaid and Veterans.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| SUFFOLK PRIMARY HEALTH, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2026 | Medicare/Medicaid |
| CENCORA, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| BECTON, DICKINSON AND COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| TOLMAR, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy |
| NOVARTIS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| LIFEPOINT HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| KYVERNA THERAPEUTICS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy |
| CENTENE CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| HARMONY FOODS, LLC D/B/A SCN BESTCO, FORMALLY REPORTED AS, SANTA CRUZ HEALTHCARE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| GRINDR LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| FERRING PHARMACEUTICALS INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ELI LILLY AND COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy |
| PLANET FITNESS HOLDINGS, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| CONSENSUS CLOUD SOLUTIONS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| CHSPSC, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ROMER INSTITUTE OF STROKE AND NEUROLOGY (RISN) | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Medical/Disease Research/Clinical Labs |
| TAPESTRYHEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| TENET BUSINESS SERVICES CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| TEXAS CHILDREN'S HOSPITAL | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ARDENT HEALTH SERVICES | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| UNIVERSITY OF COLORADO HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| EMPOWER MENTAL HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Veterans |
| UNITEDHEALTH GROUP INC | UNITEDHEALTH GROUP, INC. | Q2 2026 | Financial Institutions/Investments/Securities, Medicare/Medicaid, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 23 | 2 |
| 2025 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Sara Morse. See the Capitol Clarity rankings and method.